510(k) Report

510(k) · Cleared

Recalled · 2004

Crosseal Application Device

K030032510(k) TraditionalCleared Mar 21, 200377-day reviewClass II21 CFR 880.5570Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Omrix Biopharmaceuticals, Inc. · FMI Needle, Hypodermic, Single Lumen

Cleared on Mar 21, 2003 as substantially equivalent to K973510 (Immuno-U.S., Inc., 1997) and 1 other predicate after a 77-day review. Its family tree reaches back 4 generations to 1987. It has been recalled once.

Decided
Mar 21, 2003
Review
77 days
Class
Class II
Product code
FMI
Recalls
1
Predicates
2

Its longest line of descent runs back 4 generations to K872565 (1987). 5 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 4 generations backK872565 Duoflo DispenserHemaedics, Inc. · 1987
  2. 3 generations backK964833 Rmi Dual Fluid Irrigating SyringeResearch Medical, Inc. · 1997
  3. 2 generations backK973510 Duploject (0.5/1.0 ML, 2.0 ML, 5.0 ML)Immuno-U.S., Inc. · 1997
  4. 1 generation backK981089 Tissomat and Spray SetBaxter Healthcare Corp · 2000
  5. This deviceK030032 Crosseal Application DeviceOmrix Biopharmaceuticals, Inc. · 2003
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K872565Duoflo DispenserHemaedics, Inc.1987—
−3K964833Rmi Dual Fluid Irrigating SyringeResearch Medical, Inc.1997—
−2K973510Duploject (0.5/1.0 ML, 2.0 ML, 5.0 ML)Immuno-U.S., Inc.1997—
−1K981089Tissomat and Spray SetBaxter Healthcare Corp2000—
0 (this device)K030032Crosseal Application DeviceOmrix Biopharmaceuticals, Inc.2003—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198810
FIG. 1 — Lineage of K030032, 1987–2003Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FMI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FMI device

  1. #1 K252886 Pen Needlescore 14.5 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K973510Duploject (0.5/1.0 ML, 2.0 ML, 5.0 ML)
Summary page 1
…was Prepared: March 2003 Name of Device: CrossealTMApplication Device Identification of Predicate Devices: Duploject‘Y Baxter Healthcare Corporation, Hyland b u n 0 K973510 Mixject@Dispensing Pin with Detachable Vial Holder Medimop Medical Projects, Ltd. (Israel) K963583 Tissornat@and Spray Set Baxt…
Immuno-U.S., Inc.1997—
*K981089Tissomat and Spray Set
Summary page 1
…xject@Dispensing Pin with Detachable Vial Holder Medimop Medical Projects, Ltd. (Israel) K963583 Tissornat@and Spray Set Baxter Healthcare Corporation, Hyland h m u n o K981089 Description of Device: The CrossealTY Application Device is a sterile, single-use, disposable two-syringe device used for the…
Baxter Healthcare Corp2000—

Also cleared against K973510: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 6, 2004Not classifiedZ-1497-04Other5 mL Crosseal fibrin sealant (human) is difficult to expel from the device resulting in product leakage from the vial insertion port .

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 5 companies; a new generation was cleared every 2.7 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • 3 other devices also cite its predicate K973510.

How does its category compare?

All FMI devices

FMI Needle, Hypodermic, Single Lumen: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FMI

11in 2025

2007: 152008: 102009: 72010: 152011: 122012: 172013: 112014: 142015: 102016: 202017: 92018: 202019: 122020: 112021: 182022: 232023: 182024: 32025: 112026 (partial year): 12
2007high 23 (2022) · low 3 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FMI

141in 2025

2007: 71 days median2008: 85 days median2009: 177 days median2010: 119 days median2011: 113 days median2012: 107 days median2013: 87 days median2014: 155 days median2015: 89 days median2016: 217 days median2017: 253 days median2018: 176 days median2019: 186 days median2020: 263 days median2021: 143 days median2022: 189 days median2023: 112 days median2024: 90 days median2025: 141 days median2026 (partial year): 119 days median
2007high 263 (2020) · low 71 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FMI

1in 2024

2007: 22008: 42009: 32010: 792011: 52012: 12013: 12014: 32015: 12017: 162019: 52020: 32021: 72023: 22024: 12026 (partial year): 1, 1 Class I
2007high 79 (2010) · low 0 (2016)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · FMI

2,424in 2025

2007: 2082008: 1772009: 2632010: 2492011: 2402012: 2152013: 2552014: 2872015: 5672016: 9412017: 1,5472018: 2,3982019: 4,8962020: 4,2452021: 4,5322022: 4,8852023: 4,9862024: 4,0532025: 2,424
2007high 4,986 (2023) · low 177 (2008)2025

MAUDE reports naming product code FMI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200715712208
200810854177
200971773263
20101511979249
2011121135240
2012171071215
201311871255
2014141553287
201510891567
2016202170941
20179253161,547
20182017602,398
20191218654,896
20201126334,245
20211814374,532
20222318904,885
20231811224,986
202439014,053
20251114102,424
2026121191 (1)—

What is it indicated for?

The CrossealTMApplication Device is intended for the simultaneous topical application of the two biological components of CrossealTMFibrin Sealant via dripping (no air pressure) or via spraying (with air pressure utilizing the pressure regulator unit) onto the surface of the liver in patients undergoing liver surgery.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K030032: Crosseal Application Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K030032

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026